As of Jan 23
| -0.03 / -3.85%|
The 2 analysts offering 12-month price forecasts for Fibrocell Science Inc have a median target of 2.00, with a high estimate of 3.00 and a low estimate of 1.00. The median estimate represents a +166.67% increase from the last price of 0.75.
The current consensus among 2 polled investment analysts is to Buy stock in Fibrocell Science Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.